Literature DB >> 23509304

Changing patterns of anal canal carcinoma in the United States.

Rebecca A Nelson1, Alexandra M Levine, Leslie Bernstein, David D Smith, Lily L Lai.   

Abstract

PURPOSE: Persistent human papillomavirus infection is associated with squamous cell carcinoma of the anal canal (SCCA). With changing sexual behaviors, SCCA incidence and patient demographics may also have changed in recent years.
METHODS: The Surveillance, Epidemiology, and End Results public-use data set from 1973 to 2009 was analyzed to determine incidence trends for and demographic factors characterizing SCCA. Joinpoint analyses identified time points when incidence rates changed. For comparison, similar analyses were conducted for anal adenocarcinoma.
RESULTS: Joinpoint analyses identified 1997 as the single inflection point among 11,231 patients with SCCA, at which the slope of incidence rates statistically increased (1997 to 2009 v 1973 to 1996: risk ratio [RR], 2.2; 95% CI, 2.1 to 2.3). Annual percent change (APC) increased for all SCCA stages and was the greatest for anal carcinoma in situ (CIS; APC, 14.2; 95% CI, 10.2 to 18.4). Demographic changes characterizing later versus earlier time period included younger age at diagnosis and rising incidence rates in all stage, sex, and racial groups. During 1997 to 2009, women were less likely to present with CIS (RR, 0.3; 95% CI, 0.3 to 0.3) but more likely to present with localized (RR, 1.2; 95% CI, 1.1 to 1.3) and regional SCCA (RR, 1.5; 95% CI, 1.4 to 1.7). In contrast, adenocarcinoma APCs among 1,791 patients remained stable during this time period.
CONCLUSION: CIS and SCCA incidence increased dramatically after 1997 for men and women, although men were more likely to be diagnosed with CIS. These changes likely resulted from available screening in men and argue for efforts to identify high-risk individuals who may benefit from screening.

Entities:  

Mesh:

Year:  2013        PMID: 23509304      PMCID: PMC3753461          DOI: 10.1200/JCO.2012.45.2524

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  35 in total

Review 1.  Anal human papillomavirus and anal cancer.

Authors:  P Tilston
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

2.  Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men.

Authors:  J M Palefsky; E A Holly; M L Ralston; N Jay
Journal:  J Infect Dis       Date:  1998-02       Impact factor: 5.226

3.  A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic.

Authors:  Elizabeth Y Chiao; Susan E Krown; Elizabeth A Stier; Deborah Schrag
Journal:  J Acquir Immune Defic Syndr       Date:  2005-12-01       Impact factor: 3.731

4.  Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.

Authors:  J M Palefsky; E A Holly; M L Ralston; R M Greenblatt
Journal:  J Infect Dis       Date:  2000-12-29       Impact factor: 5.226

5.  Prevalence and risk factors for anal squamous intraepithelial lesions in women.

Authors:  E A Holly; M L Ralston; T M Darragh; R M Greenblatt; N Jay; J M Palefsky
Journal:  J Natl Cancer Inst       Date:  2001-06-06       Impact factor: 13.506

6.  Natural history of cervicovaginal papillomavirus infection in young women.

Authors:  G Y Ho; R Bierman; L Beardsley; C J Chang; R D Burk
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

7.  Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women's interagency HIV study.

Authors:  L S Massad; L Ahdieh; L Benning; H Minkoff; R M Greenblatt; H Watts; P Miotti; K Anastos; M Moxley; L I Muderspach; S Melnick
Journal:  J Acquir Immune Defic Syndr       Date:  2001-08-15       Impact factor: 3.731

8.  Efficient interval estimation for age-adjusted cancer rates.

Authors:  Ram C Tiwari; Limin X Clegg; Zhaohui Zou
Journal:  Stat Methods Med Res       Date:  2006-12       Impact factor: 3.021

9.  Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000.

Authors:  Lisa G Johnson; Margaret M Madeleine; Laura M Newcomer; Stephen M Schwartz; Janet R Daling
Journal:  Cancer       Date:  2004-07-15       Impact factor: 6.860

Review 10.  The role of human papillomaviruses in anogenital cancers.

Authors:  M Melbye; M Frisch
Journal:  Semin Cancer Biol       Date:  1998-08       Impact factor: 15.707

View more
  64 in total

1.  A qualitative investigation among men who have sex with men on the acceptability of performing a self- or partner anal exam to screen for anal cancer.

Authors:  Seyram A Butame; Sylvia Lawler; Joseph T Hicks; J Michael Wilkerson; Lu-Yu Hwang; Sarah Baraniuk; Michael W Ross; Elizabeth Yu Chiao; Alan G Nyitray
Journal:  Cancer Causes Control       Date:  2017-08-04       Impact factor: 2.506

Review 2.  Basic Science, Epidemiology, and Screening for Anal Intraepithelial Neoplasia and Its Relationship to Anal Squamous Cell Cancer.

Authors:  Kurt G Davis; Guy R Orangio
Journal:  Clin Colon Rectal Surg       Date:  2018-11-02

Review 3.  Multidisciplinary Approach to the Management and Treatment of Anal Dysplasia.

Authors:  Jeffrey Douaiher; Sean J Langenfeld
Journal:  Clin Colon Rectal Surg       Date:  2018-11-02

4.  The effect of dose escalation for large squamous cell carcinomas of the anal canal.

Authors:  R N Prasad; J Elson; J Kharofa
Journal:  Clin Transl Oncol       Date:  2018-04-05       Impact factor: 3.405

Review 5.  Advances in the Management of Anal Cancer.

Authors:  Diana R Julie; Karyn A Goodman
Journal:  Curr Oncol Rep       Date:  2016-03       Impact factor: 5.075

6.  A wide field-of-view scanning endoscope for whole anal canal imaging.

Authors:  Chao Han; Jiangtao Huangfu; Lily L Lai; Changhuei Yang
Journal:  Biomed Opt Express       Date:  2015-01-27       Impact factor: 3.732

7.  Risk of Invasive Anal Cancer in HIV-Infected Patients With High-Grade Anal Dysplasia: A Population-Based Cohort Study.

Authors:  Yotam Arens; Michael Gaisa; Stephen E Goldstone; Yuxin Liu; Juan Wisnivesky; Carlie S Sigel; Talia H Swartz; Keith Sigel
Journal:  Dis Colon Rectum       Date:  2019-08       Impact factor: 4.585

8.  Investigating epidemiologic trends and the geographic distribution of patients with anal squamous cell carcinoma throughout Canada.

Authors:  L Cattelan; F M Ghazawi; M Le; E Savin; A Zubarev; F Lagacé; D Sasseville; K Waschke; I V Litvinov
Journal:  Curr Oncol       Date:  2020-06-01       Impact factor: 3.677

9.  Clinical and Economic Evaluation of Treatment Strategies for T1N0 Anal Canal Cancer.

Authors:  Ashish A Deshmukh; Hui Zhao; Prajnan Das; Elizabeth Y Chiao; Yi-Qian Nancy You; Luisa Franzini; David R Lairson; Michael D Swartz; Sharon H Giordano; Scott B Cantor
Journal:  Am J Clin Oncol       Date:  2018-07       Impact factor: 2.339

10.  Approaching a decade since HPV vaccine licensure: Racial and gender disparities in knowledge and awareness of HPV and HPV vaccine.

Authors:  Eric Adjei Boakye; Betelihem B Tobo; Rebecca P Rojek; Kahee A Mohammed; Christian J Geneus; Nosayaba Osazuwa-Peters
Journal:  Hum Vaccin Immunother       Date:  2017-08-30       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.